Allogeneic hematopoietic stem cell transplantation with the modified myeloablative conditioning regimen for children with chronic active Epstein-Barr virus infection.
Yanhui LuoAng WeiBin WangGuanghua ZhuRui ZhangChenguang JiaYan YanXuan ZhouJun YangMaoquan QinTianyou WangPublished in: Pediatric investigation (2022)
Allo-HSCT with the modified MAC regimen is safe and effective for pediatric CAEBV. This treatment benefits patients with HLH or active disease. Patients with Grade III-IV aGVHD may be associated with worse outcomes.